Skip to main content
Home

Breadcrumb

  1. Coronavirus

What data has to be entered in the reporting system?

Answer

Information on the person treated (e.g. sociodemographic data), on the treating physician, and on the treatment – i.e. the date of prescription, previous treatment with medicinal cannabis products and its duration, indications (including primary and relevant secondary diagnoses), medicinal cannabis product (product name, dosage form, total THC and CBD content, dosage), symptom-relevant concomitant medication (product, dosage), effects, adverse effects and treatment-related changes in symptoms.

To allow treatment outcomes to be monitored, data is to be collected several times – at the time of first prescription (baseline data collection), after one year and after two years of treatment, or earlier, if treatment is terminated before the end of the first or second year. Based on this data, prescription practices are to be tracked and the treatment effects observed in various indications are to be documented. This will facilitate the evaluation of the revised Act and serve as a guide for the cantonal enforcement authorities and physicians providing treatment. In addition, the data collected should also provide a basis for further clinical research.

Related Questions

I’m pregnant and have questions about the coronavirus. Who should I contact?
I am infected with the coronavirus. Can I breastfeed my child?
I am pregnant and I’ve contracted the coronavirus. Is my baby at risk?
I’m pregnant and infected with the coronavirus and the baby is due. What should I do?
Can COVID-19 (coronavirus disease) be treated with antibiotics?
FAQ Software by 10+

Navigation

  • Krankenversicherung
  • Ambulant vor Stationär
  • Gesetzgebung Krebsregistrierung
  • CFQ
    • Strategie und Ziele
    • Finanzierung und Reglement
    • Formulaire de demande
    • Beurteilung der Gesuche
  • Cannabis
    • Cannabis for medical purposes
  • Coronavirus Gesundheitsfachpersonen
    • Allgemeine Informationen zu Covid-19
    • Impfstrategie und -empfehlungen
    • Covid-19-Impfung
    • Covid-Zertifikat (für Gesundheitsfachpersonen)
    • Unerwünschte Impferscheinungen
    • Krankheit und Symptome
    • Schutzmassnahmen
    • Umsetzung in der Praxis
    • Schwangere, Neugeborene und Migrationsbevölkerung
    • Sozialmedizinische Institutionen und Patientenverfügungen
    • Zielgruppen
    • Umgang mit Erkrankten
  • Coronavirus
    • Infection and risks
    • COVID certificate
    • Vaccination
    • Isolation and contact with a person who has tested positive
    • Children and school
    • Disease, symptoms, treatment
    • Masks
    • Travel
    • Pregnancy
    • SwissCovid app
    • Tests

Language:

  • English
  • Deutsch
  • Italian
  • Français
Home

Footer

  • made in ?? by zehnplus